A novel therapy for the treatment of pyoderma gangrenosum.

Pyoderma gangrenosum (PG) is an uncommon, chronic, painful, ulcerative skin disease of unknown origin, often associated with systemic diseases including inflammatory bowel disease, rheumatoid arthritis; monoclonal gammopathy, hepatitis and myeloproliferative disorders. The mainstay of therapy for PG has been high-dose corticosteroids but not all patients have a favourable outcome. Other systemic agents have also been used such as cyclosporine, azathioprine, cyclophosphamide and tacrolimus. However, all these systemic therapies can be complicated by serious side effects. In this paper, we report a series of four patients with pyoderma gangrenosum treated successfully with topical cyclosporine. No side-effects were observed in any of the patients and there was minimal systemic absorption of the topical cyclosporine.
AuthorsN Z Azizan, H B Gangaram, S H Hussein
JournalThe Medical journal of Malaysia (Med J Malaysia) Vol. 63 Issue 1 Pg. 51-4 (Mar 2008) ISSN: 0300-5283 [Print] Malaysia
PMID18935734 (Publication Type: Journal Article)
Chemical References
  • Cyclosporine
  • Administration, Topical
  • Adult
  • Cyclosporine (administration & dosage)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pyoderma Gangrenosum (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: